NeuroPace Inc - רווח נקי למניה בארבעת הרבעונים האחרונים NPCE

The price action history for NeuroPace, Inc. (NPCE) on the GURU.Markets platform demonstrates a profit level of 26.00. NeuroPace, Inc. (NPCE) dominates the epilepsy treatment segment by implementing intelligent RNS systems to suppress seizures. The company has modernized production through AI-driven robotization of assembly and quality control processes. Financial success is based on the sale of high-tech neurostimulators and subsequent global patient service support.

Year-over-year (YoY) EPS growth (TTM) measures the dynamics of net income per share, eliminating quarterly gaps to reveal the true earnings trend. Investors utilize the historical EPS YoY TTM delta to determine if an asset is overvalued during extreme growth peaks. For NeuroPace, Inc. (NPCE), this metric reflects the scaling efficiency of neurostimulator implantations. The stability of this metric confirms control over marketing expenses while maintaining a safe level of liquidity.